User profiles for Romain Ragonnet

Romain Ragonnet

Monash University
Verified email at monash.edu
Cited by 1011

Risk of active tuberculosis in the five years following infection... 15%?

JM Trauer, N Moyo, EL Tay, K Dale, R Ragonnet… - Chest, 2016 - Elsevier
Background It is often stated that the lifetime risk of developing active TB after an index infection
is 5% to 10%, one-half of which accrues in the 2 to 5 years following infection. The goal …

[HTML][HTML] Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review

D Shaweno, M Karmakar, KA Alene, R Ragonnet… - BMC medicine, 2018 - Springer
Background Tuberculosis (TB) transmission often occurs within a household or community,
leading to heterogeneous spatial patterns. However, apparent spatial clustering of TB could …

[HTML][HTML] The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains

…, MT Meehan, TN Doan, R Ragonnet… - International Journal of …, 2017 - Elsevier
Objectives Multidrug-resistant tuberculosis (MDR-TB) is a threat to tuberculosis (TB) control.
To guide TB control, it is essential to understand the extent to which and the circumstances …

Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology

…, MT Meehan, S Ogunlade, R Ragonnet… - Paediatric Respiratory …, 2021 - Elsevier
Mathematical modelling has played a pivotal role in understanding the epidemiology of and
guiding public health responses to the ongoing coronavirus disease of 2019 (COVID-19) …

[HTML][HTML] Understanding how Victoria, Australia gained control of its second COVID-19 wave

…, ES McBryde, AC Cheng, B Sutton, R Ragonnet - Nature …, 2021 - nature.com
During 2020, Victoria was the Australian state hardest hit by COVID-19, but was successful
in controlling its second wave through aggressive policy interventions. We calibrated a …

[HTML][HTML] High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?

R Ragonnet, JM Trauer, JT Denholm, BJ Marais… - BMC infectious …, 2017 - Springer
Background Globally 3.9% of new and 21% of re-treatment tuberculosis (TB) cases are
multidrug-resistant or rifampicin-resistant (MDR/RR), which is often interpreted as evidence that …

[HTML][HTML] Understanding COVID-19 dynamics and the effects of interventions in the Philippines: A mathematical modelling study

…, JG Wood, LV Le, ES McBryde, R Ragonnet… - The Lancet Regional …, 2021 - thelancet.com
Background COVID-19 initially caused less severe outbreaks in many low- and middle-income
countries (LMIC) compared with many high-income countries, possibly because of …

Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision …

…, MT Meehan, N Scott, R Ragonnet… - Journal of …, 2019 - academic.oup.com
Background Latent tuberculosis infection (LTBI) is a critical driver of the global burden of
active TB, and therefore LTBI treatment is key for TB elimination. Treatment regimens for LTBI …

Ethics of selective restriction of liberty in a pandemic

J Cameron, B Williams, R Ragonnet, B Marais… - Journal of Medical …, 2021 - jme.bmj.com
Liberty-restricting measures have been implemented for centuries to limit the spread of
infectious diseases. This article considers if and when it may be ethically acceptable to impose …

[HTML][HTML] Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries

R Ragonnet, JM Trauer, N Geard, N Scott, ES McBryde - BMC medicine, 2019 - Springer
Background Tuberculosis (TB) control efforts are hampered by an imperfect understanding
of TB epidemiology. The true age distribution of disease is unknown because a large …